Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis
Author:
Affiliation:
1. Department of Clinical Therapeutics; National and Kapodistrian University of Athens, School of Medicine; Athens Greece
Publisher
Wiley
Subject
Hematology
Reference32 articles.
1. Renal impairment in patients with multiple myeloma: A consensus statement on behalf of the International Myeloma Working Group;Dimopoulos;J Clin Oncol,2010
2. Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005
3. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: An ERA-EDTA Registry study;Tsakiris;Nephrol Dial Transplant,2010
4. Novel approaches for reducing free light chains in patients with myeloma kidney;Hutchison;Nat Rev Nephrol,2012
5. Current treatments for renal failure due to multiple myeloma;Kastritis;Expert Opin Pharmacother,2013
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of daratumumab in therapy of patients with newly diagnosed multiple myeloma complicated by dialysis-dependent kidney failure: literature review and clinical observation;MD-Onco;2023-09-20
2. Risk nomogram for assessing renal recovery in patients with newly diagnosed multiple myeloma-related renal impairment;Current Problems in Cancer;2023-08
3. Multiple Myeloma and Kidney Impairment at Diagnosis: A Nephrological Perspective from an Eastern European Country;Medicina;2023-07-18
4. Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report;BMC Nephrology;2023-07-06
5. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group;The Lancet Oncology;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3